AUG 13, 2019 8:02 AM PDT

Novel Drug Target for Dilating Microvessels

WRITTEN BY: Nouran Amin

Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood vessels that more blood is needed. Their studies were particularly helpful in diastolic heart failure which is a characterized by the inability of the left ventricle to relax and fill blood adequately. the natural inhibitor of that chemical goes up and communication with upstream blood vessels goes down. And, when they bring the inhibitor down, it reduces the heart dysfunction, they report in the journal Circulation: Heart Failure.

Learn more on how our hearts pump blood:

"What we are talking about here even many cardiologists cannot see," says Dr. Zsolt Bagi from Augusta University’s Department of Physiology who was refereeing to the microvasculature of the heart muscle.

Although when we think of heart failure—thoughts of high cholesterol, high blood pressure, and smoking start to surface. However, heart failure can also arise from microvascular dysfunction.

In the study, published in the journal Circulation: Heart Failure, researchers found that the chemical adenosine—known to facilitate dilation—will not function effectively if levels if its inhibitory compound, adenosine kinase, are increased.

“In a healthy state, the two provide balance for each other, but adenosine levels are typically somewhat higher. If you are healthy, when a portion of your heart needs more blood and oxygen for that walk or to hike up some stairs, adenosine levels go up and adenosine kinase levels decrease, which is good,” says MD/PhD student Alec Davila.

“Now they've shown that in their animal model of disease, giving a drug that blocks adenosine kinase boosts the intrinsic adenosine production back where we need it, which is also good,” says Bagi.

Researchers have found that adding the adenosine kinase inhibitor has improved the dilation of blood vessels in both animal and human microvessels.

"The novelty here is that adenosine really amplifies the signal," says Bagi. “The adenosine kinase inhibitor they used appears to be pretty specific, and is being looked at as well for epilepsy, where levels of adenosine kinase also are high.”

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
New Painkiller More Effective than Opioids Discovered in Mud
Researchers have discovered a new painkiller dubbed to be as effective as opioids, only minus their disadvantages, from a 16-year old mud sample found near...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
JAN 20, 2020
Cancer
JAN 20, 2020
Did you know these non-cancer drugs can also fight cancer?
A study from MIT. Harvard and the Dana-Farber Cancer Institute has concluded that almost 50 existing non-oncological drugs have anti-cancer properties capa...
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
Treating stroke with low dose of clot-busting drug
A study concludes that a low-dose of the clot-busting drug—tenecteplase—may be beneficial for eligible stroke patients that do not need an inte...
Loading Comments...